5th Annual Discovery Partnerships 2014

Date: 19-May-14 to 20-May-14
Location: Mövenpick Hotel Berlin / Berlin / Germany
Category: Conferences & Trade Fairs

Summary:

Understanding the drivers for discovery partnerships - Defining realistic goals - Finding the right partner!

Description:

In recent years we have seen a slow but steady paradigm shift in how pharmaceutical companies approach early drug discovery. The role of discovery partnerships in a high-failure-rate industry such as bio/pharma is thus pivotal for enhancing innovation while de-risking in the pre-clinical stages. Collaborative capabilities, when well developed, implemented and adopted combined with a realistic assessment of resources will define the value for science, infrastructure and business development in your company.

Our 5th annual Discovery Partnerships forum is an exclusive meeting point for interviewing potential partners, for informing yourself regarding the latest trends and for better understanding what type of partnership you should be investing in!

Join the only European non-clinical Discovery Partnerships forum and benefit from:

- The participation of high-level experts from
pharma, CROs, biotech and academia
sharing from the long-year experience
- An interactive program which values
networking and enables all participants to
actively discuss their “burning” issues
- More than 10 case-studies analysing and
arguing best practice methods for initiating
& managing innovation-driven alliances

Price - contact for detailed conditions: from €2549

Time: On Monday May 19, 2014 at 9:00 am and ends Tuesday May 20, 2014 at 5:00 pm.

Visitors

Open to all.

Exhibitors

Peter Simpson - AstraZeneca plc, Katja Rosenkranz - Ascenion GmbH, Frank Grams - Sanofi, Wen-Hwa Lee - Structural Genomics Consortium Oxford, Kristof Van Emelen - Janssen Pharmaceutica N.V., Jan Schultz - Mercachem B.V.

Go to event website

EIN News provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See: